Infection by Enterotoxigenic Escherichia coli (ICD-11: 1A03.1)

1. Introduction

Infection by enterotoxigenic Escherichia coli (ETEC) represents one of the leading causes of acute diarrhea worldwide, affecting millions of people annually. This condition is caused by specific strains of E. coli that produce enterotoxins capable of stimulating excessive fluid secretion in the intestine, resulting in characteristic watery diarrhea.

ETEC is particularly relevant in two main clinical contexts: as the predominant cause of diarrhea in young children in developing countries, where it represents a significant threat to child health, and as the most common etiological agent of so-called "traveler's diarrhea," affecting people who visit regions with inadequate sanitary conditions.

The clinical importance of this infection cannot be underestimated. Although generally self-limited in healthy adults, ETEC can cause severe dehydration, especially in children under five years of age and in vulnerable populations. The morbidity and mortality associated with severe dehydration make this condition a significant global public health problem.

Correct coding of ETEC infection is critical for several reasons. First, it enables appropriate epidemiological tracking of this condition, essential for implementation of public health measures. Second, it facilitates appropriate allocation of resources for treatment and prevention. Third, it ensures precise documentation of the diagnosis, fundamental for continuity of care and surveillance studies. The transition to ICD-11 offers greater specificity in the classification of different strains of E. coli, improving diagnostic accuracy and the quality of health data.

2. Correct ICD-11 Code

Code: 1A03.1

Description: Infection due to enterotoxigenic Escherichia coli

Parent category: 1A03 - Intestinal infections due to Escherichia coli

Official definition: Infection due to Escherichia coli caused by strains of enterotoxigenic E. coli (ETEC), which produce special toxins that stimulate the intestinal lining, causing it to secrete excessive fluid, producing diarrhea. ETEC strains continue to be one of the leading causes of childhood diarrhea in developing countries and diarrhea in travelers visiting these countries.

Code 1A03.1 is part of the hierarchical classification system of ICD-11, positioned specifically within bacterial intestinal infections. This classification allows clear differentiation between the various pathotypes of E. coli, each with distinct pathogenic mechanisms and specific clinical implications.

The structure of the code reflects the systematic organization of ICD-11: the first character "1" indicates infectious diseases; "1A" specifies bacterial intestinal infections; "1A03" delimits infections due to E. coli; and finally "1A03.1" precisely identifies the enterotoxigenic strain. This specificity is fundamental to distinguish ETEC from other pathotypes such as EPEC, EIEC, EHEC, and EAEC, each with their own clinical and epidemiological characteristics.

The correct use of this code requires laboratory confirmation or strong clinical and epidemiological evidence of ETEC infection, differentiating it from other causes of infectious diarrhea.

3. When to Use This Code

Code 1A03.1 should be used in specific clinical situations where there is confirmed or highly suggestive evidence of infection by enterotoxigenic E. coli:

Scenario 1: Traveler's diarrhea with laboratory confirmation A previously healthy adult develops profuse watery diarrhea 24-48 hours after arriving in a region with poor sanitary conditions. Stool culture with specific tests for enterotoxins (LT and/or ST) confirms ETEC. This is the classic scenario where 1A03.1 is appropriate, with definitive laboratory confirmation of the pathogen.

Scenario 2: Acute diarrhea in an infant with epidemiological evidence An 18-month-old child presents with abundant watery diarrhea, without blood or mucus, with sudden onset. There is a documented outbreak of ETEC in the community or daycare facility the child attends. Even without individual laboratory confirmation, strong epidemiological evidence justifies the use of code 1A03.1, especially when laboratory resources are limited.

Scenario 3: Institutional outbreak with microbiological identification Multiple patients in a long-term care facility simultaneously develop watery diarrhea. Epidemiological investigation identifies a common source of contamination and laboratory tests confirm ETEC in representative samples. All clinically compatible cases within the outbreak can be coded as 1A03.1.

Scenario 4: Secretory diarrhea in a child with dehydration An 8-month-old infant presents with profuse watery diarrhea of the "rice water" type, without high fever or signs of intestinal invasion. The clinical presentation is characteristic of secretory diarrhea, and rapid tests or PCR confirm the presence of enterotoxin genes from ETEC. Code 1A03.1 is appropriate with documentation of the toxin produced.

Scenario 5: Imported case with travel history A patient returns from international travel and develops watery diarrhea within one week after returning. There are no signs of dysentery or systemic complications. Stool culture or molecular tests identify ETEC. Code 1A03.1 adequately captures this diagnosis, and it is important to document the travel history as epidemiological context.

Scenario 6: Nosocomial diarrhea with laboratory identification A hospitalized patient develops watery diarrhea after 72 hours of hospitalization. Investigation of nosocomial diarrhea identifies ETEC as the causative agent through molecular methods. Code 1A03.1 is appropriate and may be complemented with codes indicating nosocomial origin of the infection.

In all these scenarios, the presence of watery diarrhea without blood, absence of signs of significant intestinal invasion, and confirmation or strong evidence of ETEC are key elements for using code 1A03.1.

4. When NOT to Use This Code

It is essential to recognize situations where code 1A03.1 is not appropriate, even in the presence of diarrhea or E. coli infection:

Bloody diarrhea or dysentery: When the patient presents with bloody diarrhea, high fever, and signs of intestinal invasion, other E. coli pathotypes are more likely. EHEC (1A03.3) causes hemorrhagic colitis, while EIEC (1A03.2) causes dysentery. ETEC characteristically does not produce bloody diarrhea.

Diarrhea in neonates younger than 6 months without confirmation: In newborns and young infants, EPEC (1A03.0) is more common than ETEC. Without specific laboratory confirmation, code 1A03.1 should not be presumed based solely on age and clinical presentation.

Hemolytic-uremic syndrome: When the patient develops complications such as hemolytic-uremic syndrome, microangiopathic hemolytic anemia, or acute renal failure, Shiga toxin-producing EHEC is the responsible pathogen, not ETEC. The correct code would be 1A03.3.

Chronic or persistent diarrhea: ETEC typically causes acute self-limited diarrhea. Cases of persistent diarrhea (more than 14 days) or chronic diarrhea suggest other diagnoses, such as EAEC or non-infectious causes, even if ETEC is initially identified.

Urinary tract infection by E. coli: E. coli is a common cause of urinary tract infection, but these strains are uropathogenic, not enterotoxigenic. Urinary tract infections require codes from the urinary tract infection category, not 1A03.1.

Asymptomatic colonization: Identification of ETEC in stool of an asymptomatic individual represents colonization, not active infection. Code 1A03.1 requires clinical manifestation of diarrheal disease.

Viral gastroenteritis or by other pathogens: When other pathogens are identified (rotavirus, norovirus, Salmonella, Shigella, Campylobacter), even if E. coli is present, the dominant agent should be coded. ETEC as a secondary finding does not justify code 1A03.1 as the primary diagnosis.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The first step is to confirm that the patient meets the criteria for ETEC infection diagnosis. Typical clinical presentation includes sudden-onset watery diarrhea, usually without high fever or significant systemic signs. The diarrhea is characteristically secretory, voluminous, and can rapidly lead to dehydration.

Laboratory confirmation is the gold standard and can be obtained through various methods. Stool culture with specific tests for heat-labile (LT) and heat-stable (ST) enterotoxins is the traditional method. Molecular techniques such as PCR for toxin genes offer greater sensitivity and speed. Immunoenzyme assays for toxin detection are also used.

In the absence of laboratory confirmation, strong epidemiological evidence may be sufficient in specific contexts. Recent travel history to endemic areas, exposure to a documented outbreak, or highly characteristic clinical presentation in an appropriate context may justify clinical diagnosis.

Also assess the presence of risk factors: age (infants and young children), travel conditions, exposure to contaminated water or food, and absence of prior immunity.

Step 2: Verify specifiers

Document the severity of infection by assessing the degree of dehydration. Mild cases present minimal or absent dehydration, moderate cases show clinical signs of dehydration (dry mucous membranes, decreased skin turgor, oliguria), and severe cases present severe dehydration with hemodynamic instability.

Record symptom duration. ETEC typically causes acute illness lasting 3-5 days, rarely exceeding one week. Prolonged duration suggests complications or alternative diagnosis.

Identify complications when present: severe dehydration, electrolyte disturbances, prerenal renal insufficiency, or need for hospitalization. This information, although it does not change the primary code 1A03.1, is important for additional codes.

Determine the acquisition context: community-acquired, travel-related, nosocomial, or outbreak-associated. This contextual information is valuable for epidemiological surveillance.

Step 3: Differentiate from other codes

1A03.0 - Infection by enteropathogenic Escherichia coli (EPEC): The main difference lies in the affected population and pathogenic mechanism. EPEC predominantly affects infants under 6 months of age, causing diarrhea through adhesion lesion and effacement of intestinal microvilli, not through enterotoxin production. Diarrhea may be more persistent than in ETEC.

1A03.2 - Infection by enteroinvasive Escherichia coli (EIEC): EIEC causes a dysenteric syndrome similar to Shigella, with bloody diarrhea, high fever, intense abdominal cramps, and tenesmus. The mechanism is invasion and destruction of the colonic epithelium, completely different from the secretory mechanism of ETEC. The presence of blood and leukocytes in stool clearly distinguishes EIEC from ETEC.

1A03.3 - Infection by enterohemorrhagic Escherichia coli (EHEC): EHEC produces Shiga toxin, causing hemorrhagic colitis with initially watery diarrhea that progresses to bloody, without significant fever. The potential complication with hemolytic-uremic syndrome is characteristic of EHEC, never of ETEC. The absence of LT/ST enterotoxin production and presence of Shiga toxin differentiates it laboratorially.

The key to differentiation lies in the type of toxin produced, clinical presentation (watery vs. bloody diarrhea), affected population, and potential complications.

Step 4: Required documentation

Adequate documentation should include:

Mandatory checklist:

Description of clinical presentation: type of diarrhea (watery, without blood), frequency, volume
Date of symptom onset and duration
Associated signs and symptoms: nausea, vomiting, cramps, fever
Assessment of hydration status and vital signs
Epidemiological history: recent travel, exposure to suspect food or water, contact with similar cases
Laboratory results: stool culture, enterotoxin tests, PCR, or justification for clinical-epidemiological diagnosis
Disease severity and presence of complications
Treatment instituted: oral or intravenous hydration, antibiotic therapy if used
Clinical course and response to treatment

Explicitly record the identification of ETEC and the diagnostic method used. If based on epidemiological evidence without laboratory confirmation, clearly document the clinical reasoning.

6. Complete Practical Example

Clinical Case:

A 32-year-old male patient, previously healthy, seeks medical care with a complaint of profuse watery diarrhea for 36 hours. He reports returning 4 days ago from a two-week trip to a region with poor sanitary conditions, where he consumed food from street vendors and untreated water.

On the second day after returning, he developed a sudden onset of watery diarrhea, described as "rice water," with a frequency of 8-10 bowel movements per day. He reports mild to moderate abdominal cramping, occasional nausea, and one episode of vomiting. He denies fever, chills, or the presence of blood or mucus in the stool. He reports weakness and dizziness upon standing.

On physical examination: patient conscious, oriented, mucous membranes slightly dry, skin turgor slightly diminished. Blood pressure 110/70 mmHg (100/65 mmHg orthostatic), heart rate 92 bpm, axillary temperature 37.2°C. Abdomen slightly distended, hyperactive bowel sounds, diffusely tender to superficial palpation, without signs of peritoneal irritation. Remainder of physical examination without significant findings.

Complementary tests ordered: complete blood count showing mild hemoconcentration (hematocrit 48%), normal leukocytes; electrolytes with mild hyponatremia (Na+ 133 mEq/L) and hypokalemia (K+ 3.2 mEq/L); renal function with urea and creatinine at the upper limit of normal, suggesting mild dehydration.

Stool sample collected for culture and pathogen investigation. Parasitological examination negative. Fecal leukocyte search negative. Stool culture identifying E. coli with specific tests confirming the presence of genes for heat-labile (LT) and heat-stable (ST) enterotoxins, confirming ETEC.

Management: vigorous oral rehydration initiated with oral rehydration solution, dietary counseling, symptomatic treatment for cramping. Patient showed progressive improvement, with reduction in bowel movement frequency after 48 hours and complete resolution of symptoms in 5 days.

Coding Step by Step:

Criteria Analysis:

Profuse watery diarrhea without blood or mucus - compatible with ETEC
Sudden onset after exposure in a risk area - typical epidemiological context
Absence of high fever or signs of intestinal invasion - rules out EIEC and EHEC
Laboratory confirmation of E. coli producing LT and ST enterotoxins - definitive diagnosis of ETEC
Mild to moderate dehydration - typical complication
Self-limited course with response to rehydration - expected clinical course

Code chosen: 1A03.1 - Infection due to enterotoxigenic Escherichia coli

Complete Justification: Code 1A03.1 is appropriate because there is definitive laboratory confirmation of ETEC through identification of enterotoxin genes. The clinical presentation is characteristic: secretory watery diarrhea with sudden onset, without significant fever, without blood in the stool, in the context of travel to an endemic area. The absence of fecal leukocytes confirms a non-invasive mechanism. The self-limited course and response to rehydration are typical of ETEC.

Applicable Complementary Codes:

Dehydration code if necessary to specify severity
Code indicating relationship with international travel, if available in the complementary coding system
Procedure codes for intravenous rehydration, if it had been necessary

This case perfectly illustrates the typical presentation of ETEC, with adequate diagnostic confirmation and precise coding.

7. Related Codes and Differentiation

Within the Same Category:

1A03.0: Infection by enteropathogenic Escherichia coli (EPEC)

When to use 1A03.0: Use this code for young infants (typically younger than 6 months) with persistent watery diarrhea, especially in developing countries. EPEC causes characteristic lesion of adherence and effacement of intestinal microvilli.

Main difference vs. 1A03.1: EPEC does not produce LT or ST enterotoxins. The affected population is predominantly neonatal. Diarrhea may be more prolonged and persistent. Laboratory diagnosis identifies eae genes (intimin) and absence of enterotoxin genes, unlike ETEC which has eltA/eltB genes (LT) or estA/estB (ST).

1A03.2: Infection by enteroinvasive Escherichia coli (EIEC)

When to use 1A03.2: Patients with dysenteric syndrome - bloody diarrhea with mucus, high fever (frequently above 38.5°C), intense abdominal cramps and tenesmus. EIEC invades epithelial cells of the colon, causing inflammation and tissue destruction.

Main difference vs. 1A03.1: EIEC causes inflammatory diarrhea with blood and abundant fecal leukocytes, while ETEC causes watery secretory diarrhea without blood. EIEC presents with clinical picture indistinguishable from shigellosis. Laboratorially, EIEC has invasion genes (ipaH) and does not produce enterotoxins. Fever is much more prominent in EIEC.

1A03.3: Infection by enterohemorrhagic Escherichia coli (EHEC)

When to use 1A03.3: Patients with hemorrhagic colitis - diarrhea initially watery that progresses to frankly bloody, usually without high fever. Risk of serious complications such as hemolytic-uremic syndrome, especially in children and elderly.

Main difference vs. 1A03.1: EHEC produces Shiga toxin (Stx), not enterotoxins. Diarrhea progresses from watery to bloody, unlike the persistent watery diarrhea of ETEC. EHEC can cause hemolytic-uremic syndrome with hemolytic anemia, thrombocytopenia and renal failure - a complication never seen in ETEC. The O157:H7 serotype is the most common EHEC.

Differential Diagnoses:

Cholera (1A00): Can be confused with ETEC due to profuse watery diarrhea of "rice water" type. It differs by greater severity and volume of diarrhea in cholera, which can reach liters per hour. Laboratory confirmation identifies Vibrio cholerae, not E. coli.

Rotavirus and other viral gastroenteritis: Present with watery diarrhea, but generally with more prominent vomiting, more common fever, and occur predominantly in seasonal outbreaks. Specific tests identify viruses, not bacteria.

Giardiasis: Can cause watery diarrhea, but typically is more subacute or chronic, with prominent abdominal distension and flatulence. Identification of Giardia cysts or trophozoites differentiates it.

Staphylococcal food poisoning: Very rapid onset (1-6 hours) with prominent vomiting. Shorter duration (12-24 hours). Preformed toxin, not active infection.

8. Differences with ICD-10

In ICD-10, infections caused by enterotoxigenic E. coli were coded in a less specific manner. The closest code was A04.1 - Intestinal infection due to enteropathogenic Escherichia coli, which in ICD-10 encompassed different E. coli pathotypes without clear differentiation.

Some systems used A04.4 - Other bacterial intestinal infections when they wanted to specify ETEC, but this resulted in loss of specificity and difficulty in epidemiological tracking.

Main changes in ICD-11:

ICD-11 introduces significantly greater specificity, creating distinct codes for each diarrheagenic E. coli pathotype. Code 1A03.1 is exclusive for ETEC, while 1A03.0 (EPEC), 1A03.2 (EIEC), 1A03.3 (EHEC) and other codes within 1A03 cover the remaining pathotypes.

This differentiation better reflects current knowledge about distinct pathogenic mechanisms, different clinical presentations, and specific epidemiological implications of each type of diarrheagenic E. coli.

Practical impact:

Greater specificity allows for more precise epidemiological surveillance, identifying transmission patterns specific to ETEC versus other pathotypes. It facilitates efficacy studies of targeted interventions, such as development of ETEC-specific vaccines.

For healthcare professionals, ICD-11 requires greater diagnostic precision, encouraging specific laboratory confirmation of the pathotype. Health information systems can now track different types of E. coli separately, improving public health data.

The transition requires updating information systems, training of coders and healthcare professionals, and adaptation of laboratory protocols for specific pathotype identification.

9. Frequently Asked Questions

How is ETEC infection diagnosed?

Definitive diagnosis requires laboratory confirmation through stool culture with identification of E. coli and specific tests for enterotoxins. Methods include PCR for toxin genes (eltA/eltB for LT, estA/estB for ST), immunoassays for toxin detection, or bioassays in cell cultures. In resource-limited settings or in documented outbreak situations, clinical-epidemiological diagnosis may be acceptable when the clinical presentation is characteristic and there is strong epidemiological evidence. A history of recent travel to endemic areas combined with typical watery diarrhea provides strong diagnostic suggestion.

Is treatment available in public health systems?

Yes, the main treatment for ETEC - oral rehydration therapy - is widely available and low-cost in public health systems worldwide. Oral rehydration solutions are considered an essential intervention by the World Health Organization. Severe cases requiring intravenous hydration are also treatable in public health services. Antibiotic therapy, when indicated, uses medications generally available in basic formularies, although its use is reserved for specific cases due to concerns about antimicrobial resistance and limited benefit in most self-limited cases.

How long does treatment last?

ETEC infection is typically self-limited, lasting 3-5 days. Supportive treatment with hydration should continue until complete resolution of diarrhea and recovery of normal hydration status. Most patients recover completely within one week. When antibiotics are prescribed (generally reserved for moderate to severe cases), the typical course is 3 days. Oral hydration should be maintained throughout the symptomatic period and for several days afterward, ensuring complete recovery of hydroelectrolytic balance. Cases with severe dehydration may require hospitalization for 24-72 hours for intensive intravenous hydration.

Can this code be used in medical certificates?

Yes, code 1A03.1 can and should be used in medical certificates when appropriate. Accurate documentation of the diagnosis is important to justify absence from work or school, especially considering that ETEC is transmissible and temporary absence may be necessary to prevent transmission to others. Certificates should specify the diagnosis in a manner understandable to the patient, and may use terminology such as "intestinal infection by enterotoxigenic E. coli" or "bacterial gastroenteritis by ETEC," accompanied by ICD-11 code 1A03.1. The period of absence generally corresponds to the duration of acute symptoms, typically 3-5 days.

Can small children develop serious complications?

Yes, infants and small children have a higher risk of complications, mainly severe dehydration. The smaller body fluid reserve and higher metabolic rate make children particularly vulnerable to rapid dehydration. Warning signs include marked decrease in urine output, lethargy, sunken eyes, depressed fontanelle in infants, crying without tears, and loss of skin turgor. Severe dehydration can lead to hypovolemic shock, acute kidney injury, and severe electrolyte disturbances. Therefore, children with ETEC require close monitoring of hydration status and early aggressive intervention with oral or intravenous rehydration when necessary.

Is there a vaccine available against ETEC?

Currently there is no widely available licensed vaccine against ETEC, although several candidates are in development. The antigenic complexity of ETEC, with multiple colonization factors and different toxins, makes vaccine development challenging. Research focuses on vaccines that induce immunity against LT and ST toxins, as well as colonization factors. An oral inactivated vaccine containing multiple strains of E. coli is available in some countries for travelers, but its efficacy is moderate and duration of protection is limited. For prevention, hygiene measures, water and food safety, and traveler education remain the main strategies.

Can ETEC cause chronic or recurrent diarrhea?

ETEC typically causes acute self-limited disease, not chronic diarrhea. However, in some children in developing countries with repeated exposure, recurrent episodes may occur due to reinfections by different strains. Rarely, after an acute episode of ETEC, some patients may develop post-infectious syndrome such as post-infectious irritable bowel syndrome, but this does not represent persistent infection. If diarrhea persists beyond 14 days, other diagnoses should be considered, including other pathogens, superinfections, or non-infectious conditions. Truly chronic diarrhea (more than 4 weeks) is not caused by ETEC and requires alternative investigation.

How to prevent ETEC infection during travel?

Prevention is based on hygiene measures and food safety precautions. Consume only bottled or treated water (boiled, filtered, or chlorinated). Avoid ice from unknown sources. Choose well-cooked foods served hot. Avoid raw salads, unpeeled fruits that you have not peeled yourself, and food from street vendors. Wash hands frequently with soap and water, especially before eating. Use hand sanitizer when water is not available. Avoid consuming unpasteurized milk and dairy products of questionable origin. For travelers to high-risk areas, some physicians prescribe prophylactic antibiotics, but this is not routinely recommended due to concerns about antimicrobial resistance and adverse effects.

Conclusion:

ICD-11 code 1A03.1 for enterotoxigenic Escherichia coli infection represents an important advance in the specific classification of intestinal infections by E. coli. Correct use of this code requires clear understanding of ETEC pathogenic mechanisms, recognition of characteristic clinical presentation, and appropriate differentiation from other E. coli pathotypes. Laboratory confirmation, when available, is fundamental for accurate coding, although strong clinical-epidemiological evidence may be sufficient in appropriate contexts. The increased specificity of ICD-11 improves epidemiological surveillance, facilitates resource allocation, and enhances the quality of public health data, contributing to better understanding and control of this important cause of global morbidity.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Infection by Enterotoxigenic Escherichia coli

Share